Search
forResearch 4 of 22
- Formulation-by-Design of Efinaconazole Spanlastic Nanovesicles for Transungual Delivery Using Statistical Risk Management and Multivariate Analytical Techniques
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- New Antifungal Agents and New Formulations Against Dermatophytes
- Effects of an online educational curriculum on knowledge and competence in managing onychomycosis
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →